Andrew Gleason, FRANZCP

Dr Gleason is affiliated with the Department of Consultation-Liaison Psychiatry at Concord Repatriation General Hospital and the Florey Institute of Neuroscience and Mental Health at the University of Melbourne in Melbourne, Australia.

Articles by Andrew Gleason, FRANZCP

Serotonin Reuptake Inhibitor and Bleeding Risk, Part 2: Gastrointestinal (GI) Bleeding, Malignancy, Pregnancy, and Surgical Considerations

ByGregg A. Robbins-Welty, MD, MS,Andrew N. Tuck, MD,Dale Marchant, FRANZCP,Andrew Gleason, FRANZCP,Richard Garrett Key, MD,Barbara Lubrano Di Ciccone, MD,Deepti A. Chopra, MBBS,Mona Mojtahedzadeh, MD,Fíona Fonseca, MD,Hermioni Lokko Amonoo, MD,Andrea DeSimone, DO,Daniel C. McFarland, DO

October 27th 2023

In this CME article, review literature on SRI-related bleeding complications in patients with GI bleeding, malignancy, perioperative settings, pregnancy, and hormonal therapy.

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

September 26th 2023

In this CME article, get a better understanding of bleeding risk associated with use of serotonin reuptake inhibitors (SRIs) and review research-informed literature on related bleeding complications in patients with cardiovascular and cerebrovascular disease.

Andrew Gleason, FRANZCP

Articles by Andrew Gleason, FRANZCP

Serotonin Reuptake Inhibitor and Bleeding Risk, Part 2: Gastrointestinal (GI) Bleeding, Malignancy, Pregnancy, and Surgical Considerations

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

Latest Updated Articles

Trending on Psychiatric Times

Positive FDA Meeting for Abuse Deterrent Fentanyl Patch

Candy and Other Food Treats or Tricks

“Porosity”: Connecting 2 Western Cultural Psychiatric Discourses in Tokyo by Way of Naples

Trick or Treat: Fiddling While Rome Burns or Playing a Violin of Hope?

The Dangers of Conversion Therapy: What Chiles v Salazar Could Mean for LGBTQ+ Youth